Sydnone-based prosthetic groups for radioiodination

The potential of Strained-Promoted Sydnone-Alkyne Cycloaddition (SPSAC) for radioiodination was evaluated with model cyclooctyne-conjugated peptides. Starting with a series of sydnones with varying N<sub>3</sub> and C<sub>4</sub> substitution, a preliminary kinetic study with non-radioactive iodinated compounds highlighted the superiority of an arylsydnone substituted by a chlorine atom in C<sub>4</sub> position. Interestingly, reaction rate up to 11 times higher than using an azide was achieved with the best system. Access to <sup>125</sup>I-labelled sydnones was granted with high efficiency from arylboronic acid precursors by copper catalyzed nucleophilic substitution. Application of SPSAC on the model peptide in radiotracer conditions showed the same trend than in non-radioactive kinetic study and complete reactions could be achieved within less than an hour for the best systems. These results are favorable for use in the production of radiopharmaceuticals with heavy halogens and increase the diversity of available bioorthogonal reaction for nuclear imaging and therapy.

Authors

Institutions

Publication Details

Journal
Bioorganic & Medicinal Chemistry
Published
2024-09-03
DOI
https://doi.org/10.1016/j.bmc.2024.117904
Citations
2
Primary Topic
Click Chemistry and Applications
Type
article
Field-Weighted Citation Impact
0.50

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Sydnone-based prosthetic groups for radioiodination

François Guérard, Jean‐François Gestin, Romain Eychenne, Férid Haddad et al.
2 citations
Bioorganic & Medicinal Chemistry
Click Chemistry and Applications
0.50
article

Sydnone-based prosthetic groups for radioiodination

François Guérard, Jean‐François Gestin, Romain Eychenne, Férid Haddad, Ludovic Le Saux
article en
2 citations

Abstract

The potential of Strained-Promoted Sydnone-Alkyne Cycloaddition (SPSAC) for radioiodination was evaluated with model cyclooctyne-conjugated peptides. Starting with a series of sydnones with varying N<sub>3</sub> and C<sub>4</sub> substitution, a preliminary kinetic study with non-radioactive iodinated compounds highlighted the superiority of an arylsydnone substituted by a chlorine atom in C<sub>4</sub> position. Interestingly, reaction rate up to 11 times higher than using an azide was achieved with the best system. Access to <sup>125</sup>I-labelled sydnones was granted with high efficiency from arylboronic acid precursors by copper catalyzed nucleophilic substitution. Application of SPSAC on the model peptide in radiotracer conditions showed the same trend than in non-radioactive kinetic study and complete reactions could be achieved within less than an hour for the best systems. These results are favorable for use in the production of radiopharmaceuticals with heavy halogens and increase the diversity of available bioorthogonal reaction for nuclear imaging and therapy.

Bioorganic & Medicinal ChemistryVol. 113
Centre National de la Recherche Scientifique (FR), Inserm (FR), Centre de Recherche en Cancérologie et Immunologie Intégrée Nantes Angers (FR), IMT Atlantique (FR), Nantes Université (FR)
Labex Iron, European Cooperation in Science and Technology, Agence Nationale de la Recherche, Institut National de la Santé et de la Recherche Médicale, Institut National Du Cancer, Direction Générale de l’offre de Soins, CHIST-ERA
Openalex Percentile: Top 40%
Click Chemistry and Applications
0.50
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Sydnone-based prosthetic groups for radioiodination — François Guérard, Jean‐François Gestin, et al. · Bioorganic & Medicinal Chemistry (2024) | TGRS Research Map | TGRS